NewsBenzingaWedbush重申对Maze Therapeutics的增持评级,维持48美元的目标股价 Wedbush重申对Maze Therapeutics的增持评级,维持48美元的目标股价 Benzinga 2026.09.23 12:17 (GMT+0) Open on Benzinga Other news David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes Bernstein Maintains Market Perform on Tyson Foods, Raises Price Target to $72 Broadcom Stock Is Up Tuesday: AI Chip Diversification, Dec. 9 Earnings, Analyst Targets SharonAI Analysts Cut Their Forecasts Following Q3 Results Bernstein Downgrades PepsiCo to Underperform, Lowers Price Target to $128 If You Invested $1000 In Humana Stock 20 Years Ago, You Would Have This Much Today